With a market cap of $11.4 billion, Revvity, Inc. (RVTY) is a global health sciences company that provides advanced instruments, reagents, software, and services supporting diagnostics, genomics, drug discovery, and life sciences research. Shares of the Waltham, Massachusetts-based company have underperformed the broader market over the past 52 weeks. RVTY stock has declined 12.5% over this time frame, while the broader S&P 500 Index ($SPX) has gained nearly 13%. However, shares of the company have risen ...